Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is issuing a single source cooperative agreement to the Beckman Research Institute/City of Hope to continue the Integrated Islet Distribution Program (IIDP), which plays a critical role in supplying researchers with human islets essential for diabetes research. This program supports partnerships with specialized islet isolation facilities to prepare and distribute these valuable resources, facilitating advancements in the understanding of human islet cell biology and contributing to the development of new therapies for diabetes prevention and treatment. The initiative aligns with the Special Diabetes Program, which funds research targeting the prevention, treatment, and cure of type 1 diabetes and its complications. This solicitation, designated RFA-DK-27-147, is open only to the designated organization and will follow NIH’s standard peer-review process to ensure the merit of the application prior to funding. The contract explicitly excludes clinical trials and invites applicants to respond by the deadline of September 30, 2026. The award continues federal support through the Department of Health and Human Services to enable ongoing provision of critical scientific resources to the diabetes research community. Questions and communications related to this opportunity can be directed to the National Institutes of Health via the contact provided.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
